Diagnostics Market Expectations and Opportunities Post Pandemic

The healthcare industry has been transformed by the COVID-19 pandemic, and the diagnostic market ...

Let’s Admit We All Have Bias

Let’s just say it: Everyone is biased. Yes, even in healthcare marketing. As two ...

Improving Rare Disease Clinical Trial Design

According to the National Organization for Rare Disorders (NORD), there are over 7,000 known ...

Data-Driven Connections: Linking Rare Disease Patients to Clinical Trials, Experts, and Resources

In rare disease, every challenge is magnified, beginning with the first. Simply put, identifying ...

Working with Rare Disease Communities and Advocacy Groups

While all patient communities and advocacy groups offer patients, their families, and their caregivers ...

Shining a Spotlight on Rare Diseases

Don’t let the rare in rare disease fool you. While the definition of a ...

An Authentic Approach to LGBTQ+ Marketing Could Save Lives

Last year, 56% of the LGBTQ+ population reported discrimination when seeking medical care,1 more ...

A black women on her laptop using Talking Medicines’ Drug-GPT program. On the laptop screen it says, "Explore Voice of the Patient with Drug-GPT."

Industry Briefs June 2023

Drug-GPT Gives Marketers Access to Patient Experiences in Seconds Talking Medicines has launched the ...

Healthcare Watch June 2023

Discoveries & Innovations: NIH Finds First Treatment for Rare Skin Disorder Disabling pansclerotic morphea ...

Reducing Friction for Healthcare Consumers via Tech-Enabled Solutions

Digital healthcare technologies have their limitations but telehealth has clearly demonstrated the ability to ...